Palantir Technologies, Inc (NYSE:PLTR) on Monday announced it had been awarded a contract to continue providing a secure cloud-based data enclave to centralize data on COVID-19 by the National Institutes of Health's (NIH) National Center for Advancing Translational Sciences (NCATS). The two-year contract has a total potential value of $59.5 million.
Why Palantir's Stock Must Hold These Key Patterns: A Technical Analysis